Monday, March 22, 2021
University of Maryland School of Medicine Researchers Awarded Funding to Lead National Discussion on Active Surveillance for Men with Low Risk Prostate Cancer
Researchers at the University of Maryland School of Medicine (UMSOM) have been awarded $100,000 in funding through the Eugene Washington PCORI Engagement Awards, an initiative of the Patient-Centered Outcomes Research Institute (PCORI). The funds will support a national discussion and conference aimed at identifying evidence gaps to guide future research on the use of active surveillance to monitor low-risk prostate cancers. This approach will serve as an alternative to immediate treatment with surgery, radiation, or hormone therapy which all have potentially debilitating side effects.
Thursday, March 18, 2021
UM School of Medicine Helps Maryland Conduct State-Wide Sequencing of Variants in Positive COVID-19 Test Specimens
In an effort to monitor the spread of COVID-19 variants in the State of Maryland, University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced that UMaryland Genomics at UMSOM will perform genome sequencing of variants in at least 10 percent of COVID-19 test samples, reaching an important benchmark set by the federal government to help control the spread of these variants.
Tuesday, March 16, 2021
New Study Finds Healthcare Settings Do Not Pose Added Risk Factor for Covid-19 Infection Spread Among U.S. Healthcare Personnel
Healthcare personnel who were infected with COVID-19 faced stronger risk factors outside of the workplace than in their hospital or healthcare settings. That is the finding of a new study published today in the Journal of the American Medical association's JAMA Network Open conducted by University of Maryland School of Medicine (UMSOM) researchers and colleagues at the Centers for Disease Control and Prevention (CDC) and three other universities.
Friday, February 26, 2021
Internationally Renowned Neuroscience Researcher and Academic Leader Asaf Keller, PhD, Appointed Chair of the Department of Anatomy and Neurobiology at the UM School of Medicine
University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that prominent international neuroscientist and academic leader, Asaf Keller, PhD, who is Professor of Anatomy and Neurobiology at UMSOM, has been appointed to serve as the Chair of the Department Anatomy and Neurobiology, effective immediately. Dr. Keller has served as the Department’s Interim Chair for the past year and a half and is internationally recognized as a leader in the fields of sensory perception, chronic pain and addiction research.
Thursday, February 25, 2021
UM School of Medicine Researchers Participate in Landmark Study Detailing Sequencing of Full Human Genomes to Better Capture Genetic Diversity
Researchers at the University of Maryland School of Medicine (UMSOM) co-authored a study, published today in the journal Science, that details the sequencing of 64 full human genomes. This reference data includes individuals from around the world and better captures the genetic diversity of the human species. Among other applications, the work will enable population-specific studies on genetic predispositions to human diseases as well as the discovery of more complex forms of genetic variation.
Wednesday, February 24, 2021
UM School of Medicine Recruits New Advanced Science Communications Group in the UMSOM Office of Public Affairs & Communications
University of Maryland School of Medicine’s Assistant Dean for Public Affairs & Communications, Christopher J. Hardwick, MA, along with Dean E. Albert Reece, MD, PhD, MBA, announced today that the UMSOM has formed an Advanced Science Communications Group within the Office of Public Affairs & Communications (OPAC). The new Group will focus on broadly communicating the UMSOM faculty’s research and breakthrough discoveries to national and international audiences through a wide range of news media.
Wednesday, February 10, 2021
UM School of Medicine Researchers Release Extensive Data on Rare Variants through NHLBI TopMed Grant
Researchers at the University of Maryland School of Medicine (UMSOM) and their colleagues published a new analysis today in the journal Nature from genetic sequencing data of more than 53,000 individuals, primarily from minority populations. The early analysis, part of a large-scale program funded by the National Heart, Lung, and Blood Institute, examines one of the largest and most diverse data sets of high-quality whole genome sequencing, which makes up a person’s DNA. It provides new genetic insights into heart, lung, blood, and sleep disorders and how these conditions impact people with diverse racial and ethnic backgrounds, who are often underrepresented in genetic studies.
Tuesday, February 09, 2021
UM School of Medicine Researchers Find that Misuse of Opioid Drugs During Pregnancy Could Have Lasting Impact on Child’s Development from Infancy Through Teen Years
As the number of pregnant women using opioid drugs continues to rise, questions have been raised about the long-term health effects on children exposed to these drugs in the womb. Researchers at the University of Maryland School of Medicine now have preliminary but striking evidence that suggests that such exposure can cause long-lasting impairment in the brain’s ability to process sensory information. These impairments may give rise to autism, attention deficit hyperactivity disorder, and substance use disorders during adolescence. The landmark study, recently published in Journal of Neuroscience, used a preclinical model to study the issue and found that newborn mice exposed to the opioid fentanyl in the womb developed withdrawal symptoms and sensory processing disorders that lasted at least until adolescence.
Friday, February 05, 2021
UM School of Medicine Researchers Demonstrate Strong Immune Response for New COVID-19 Vaccine in Pre-Clinical Tests
Researchers at the University of Maryland School of Medicine (UMSOM) have found promising results in pre-clinical studies for a new experimental vaccine against COVID-19 made by Novavax. The vaccine was found to generate a robust immune response in animals exposed to the vaccine with strong data indicating safety and efficacy, according to the study published recently in the journal Nature Communications. The results have been used to begin testing the vaccine in human trials in the U.S. with a Phase 3 trial that recently launched at the UMSOM’s Center for Vaccine Development and Global Health.
Friday, February 05, 2021
Business Leader and Philanthropist Michael Greenebaum Named Vice Chair of University of Maryland School of Medicine Board of Visitors
University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, along with UMSOM Board of Visitors Chair Cynthia Egan, announced today that Michael Greenebaum, a prominent business leader and philanthropist who has served on the UMSOM’s Board since 2012, has been named Vice Chair of the Board of Visitors.